{
    "2018-10-12": [
        [
            {
                "time": "2023-10-01",
                "original_text": "AbbVie Permits US Sale of Sandoz's Humira Biosimilar",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "US",
                        "Sale",
                        "Sandoz",
                        "Humira",
                        "Biosimilar"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "3 Large-Cap Pharma Stocks Performing Better Than Industry",
                "features": {
                    "keywords": [
                        "Large-Cap",
                        "Pharma",
                        "Stocks",
                        "Performing",
                        "Industry"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "ABBV",
                        "NVS",
                        "Humira",
                        "Biosimilar",
                        "Agreement",
                        "BMY",
                        "Cancer",
                        "Deal"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie Settles With Novartis to Delay Humira Biosimilar in US",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Settles",
                        "Novartis",
                        "Delay",
                        "Humira",
                        "Biosimilar",
                        "US"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "ABBV",
                        "NVS",
                        "Humira",
                        "Biosimilar",
                        "Agreement",
                        "BMY",
                        "Cancer",
                        "Deal"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Abbvie settles Humira patent disputes with Novartis unit",
                "features": {
                    "keywords": [
                        "Abbvie",
                        "settles",
                        "Humira",
                        "patent",
                        "disputes",
                        "Novartis",
                        "unit"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}